Akademisyen
AYTEN YAZICI
PROFESÖR
KOCAELİ ÜNİVERSİTESİ TIP FAKÜLTESİ DAHİLİ TIP BİLİMLERİ BÖLÜMÜ
- Ana Dal Sağlık Bilimleri Temel Alanı
- Yan Dal Romatoloji
Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.
- Makale 160
- Proje 0
- Kitap 34
- Bildiri 296
- Patent 0
- Sanatsal 0
Scopus (SJR)
Q1
39
Q2
45
Q3
15
Q4
12
WoS (JCR)
Q1
27
Q2
34
Q3
35
Q4
15
TR Index
47
makale
Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.
Üst %1 makale
1
Üst %10 makale
26
Ort. yüzdelik
62.8%
Üst %1 payı
0.7%
Üst %10 payı
19.3%
Makaleler
YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.
Makale listesi
- 2026 SEROPREVALENCE AND ANTIBODY TITERS FOLLOWING COVID-19 INFECTION IN RHEUMATIC DISEASE PATIENTS: A COMPARATIVE CROSS-SECTIONAL STUDY YÖKSİS TR Index OpenAlex 51.3%
- 2026 Validation of the Dudley inflammatory bowel symptom questionnaire for assessing gastrointestinal symptom burden in axial spondyloarthritis YÖKSİS SJR Q2 JCR Q2 OpenAlex üst %10 OpenAlex 95.1%
- 2026 Case Report: Atypical Presentation of Nivolumab‐Induced Immune‐Related Vasculopathy Imitating Raynauds Phenomenon in Lung Cancer YÖKSİS SJR Q3 JCR Q3 OpenAlex 37.3%
- 2026 Outcomes of Vascular Interventions in Takayasu Arteritis and the Role of Biologic Therapy: A Multicenter Retrospective Study YÖKSİS SJR Q3 JCR Q3 OpenAlex 59.8%
- 2026 Exploring the genetic interaction between ERAP1/ERAP2 and HLA-B*52:01 in Takayasu arteritis YÖKSİS SJR Q1 JCR Q1 OpenAlex 34.1%
- 2026 Prognostic value of baseline clinical features in SLE: a cluster analysis YÖKSİS SJR Q1 JCR Q1 OpenAlex 65.9%
- 2026 Clinical outcomes of subglottic stenosis in granulomatosis with polyangiitis: results of an international multicenter observational study YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 92.3%
- 2026 Cardiovascular risk factor control in antiphospholipid syndrome, and differences between primary and systemic lupus erythematosus-related antiphospholipid syndrome (SURF-SLE and APS project): a cross-sectional study of 1003 individuals from 11 countries YÖKSİS SJR Q1 JCR Q1 OpenAlex 77.9%
- 2026 Case Report: Secukinumab Experience in a Patient With Coexistence of Systemic Lupus Erythematosus, Ankylosing Spondylitis, and Antiphospholipid Antibody Syndrome YÖKSİS OpenAlex 54.4%
- 2026 Screening of osteoporosis in patients with ANCA-associated vasculitis (AAV) is quite low: results from a country-wide study YÖKSİS SJR Q1 JCR Q1 OpenAlex 30.1%
- 2026 INITIAL MRI FINDINGS IN DIFFERENT INFLAMMATORY SPONDYLOARTHROPATHY SUBTYPES: A TOPOGRAPHIC ANALYSIS OF SACROILIAC JOINT INVOLVEMENT YÖKSİS TR Index OpenAlex 58.4%
- 2025 Genetic susceptibility and validation of angiographic patterns in Takayasu arteritis YÖKSİS SJR Q1 JCR Q1 OpenAlex 82.9%
- 2025 The potential of semi-quantitative and quantitative methods in predicting progression in rheumatoid arthritis-associated interstitial lung disease YÖKSİS SJR Q2 JCR Q3 OpenAlex üst %10 OpenAlex 92.7%
- 2025 Handling of missing component information for common composite score outcomes used in axial spondyloarthritis research when complete-case analysis is unbiased YÖKSİS SJR Q1 JCR Q2 OpenAlex 86.8%
- 2025 Long-term outcomes of aortic valve insufficiency in patients with Takayasu arteritis YÖKSİS SJR Q1 JCR Q1 OpenAlex 72.7%
- 2025 Prognostic significance and rationality of regular non-invasive imaging follow-up in Takayasu arteritis: A large multicenter cohort study YÖKSİS SJR Q1 JCR Q2 OpenAlex 71.5%
- 2025 Approaches to screening for rheumatoid arthritis-associated interstitial lung disease: a cross-sectional national survey of Turkish rheumatologists YÖKSİS SJR Q2 JCR Q2 OpenAlex 82.0%
- 2025 Inadequate sleep hygiene as a key factor in poor sleep quality in systemic sclerosis: an observational, cross-sectional study YÖKSİS SJR Q2 JCR Q2 OpenAlex 88.5%
- 2025 Warrick score in rheumatoid-arthritis interstitial lung disease: a promising tool for assessing the extent and progression of lung involvement YÖKSİS SJR Q2 JCR Q2 OpenAlex üst %10 OpenAlex 91.4%
- 2025 COVID-19 vaccination in patients on biologic or targeted-synthetic disease modifying anti-rheumatic drug therapy: A multi center real-world data YÖKSİS SJR Q3 JCR Q3 OpenAlex 4.5%